Bruce Power and its group of supplier partners have made a generous donation of $100,000 to the Pediatric Oncology Group of Ontario (POGO). This support will help young patients and their families as they deal with cancer diagnoses and treatment.
The funds will assist POGO in providing specialized services to children receiving treatment, survivors, and their families throughout the province.
“Bruce Power and our supplier partners believe strongly in the high-quality wrap-around care and supports POGO has developed over the years to serve its young patients and families,” said Pat Dalzell, Vice-President of Corporate Affairs, Market Development and Operational Services at Bruce Power. “By supporting POGO, families can be assured they will receive the best emotional, practical and financial support throughout their cancer care.”
The yearly partnership between the nuclear operator and its business associates helps ensure stable funding for important provincial programs.
“We are thrilled at the consistent and unyielding support Bruce Power and its supplier partners provide to Pediatric Oncology Group of Ontario year after year,” said Lauren Ettin, Chief Executive Officer of POGO. “This ongoing generosity helps us strengthen and confidently deliver vital programs to support children and youth with cancer, survivors and their families with the best possible care.”
In addition to its charitable donations, Bruce Power plays a significant role in global cancer treatment by producing medical isotopes. The company’s reactors produce Cobalt-60, which sterilizes 40 percent of the world’s medical devices and assists in treating breast cancer and brain tumors.
Moreover, Bruce Power expanded its facilities in 2022 and 2024 by adding two Isotope Production Systems for creating lutetium-177, a medical isotope used in prostate cancer therapy as well as neuroendocrine tumors. A third production system is set to be installed in Unit 6 in 2027 to enhance supply redundancy while keeping up with new medical research.
Source link
